ArticleCancer medicine2017

Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.

Danhua Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.